Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Chronic Unilateral Migraine
NCT06109389Phase 2Unknown
- Sponsor
- Alexandria University
- Start
- Oct 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic migraine (CM), sponsored by Alexandria University. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic migraine (CM)
Beyond the preview
Go deeper on NCT06109389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06109389.